Cargando…
ICIs联合治疗应用于EGFR突变靶向治疗耐药后非小细胞肺癌的研究进展
With the development of precision medicine for lung cancer, targeted therapy has greatly improved the survival and prognosis of patients with advanced non-small cell lung cancer (NSCLC), but the occurrence of acquired drug resistance ultimately leads to patients with no targeted drugs available and...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial board of Chinese Journal of Lung Cancer
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273152/ https://www.ncbi.nlm.nih.gov/pubmed/37316449 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.101.17 |